TAT and stroke disorder: Peptides that either disrupted the GluN1-Src interaction (Src48) or interfered with Panx1 phosphorylation (Tat-Panx308) were neuroprotective in vitro, and injection of Tat-Panx308 reduced brain lesion volume in an in vivo model of stroke.